ADAM8 and breast carcinoma: MMP9 and ADAM8 (a disintegrin and metalloprotease) co-regulation has been demonstrated to promote breast cancer BM, with ADAM8 reported to upregulate MMP9 and the shedding of P-selectin glycoprotein ligand (PSGL-1) from breast cancer cells.